The aim of this study was to review the safety of pediatric intraventricular endoscopy across separate age groups and to determine whether intraventricular endoscopy is associated with an increased risk of complications or reduced efficacy in infants younger than 1 year. A total of 348 consecutive neuroendoscopic procedures were undertaken. Nine different complications were identified, of which postoperative seizures (1.7%), CSF leak (3.1%), CSF infection (2.4%), and intracranial hemorrhage (1.7%) were the most common. Specifically, no significant difference in complication rate (11.9%) or infection rate (2.4%) was observed among age groups (p = 0.40 and p = 0.91, respectively). In addition, there were no perioperative deaths; 30-day mortality was 1.1%. After neuroendoscopy for CSF diversion (n = 227), a significantly higher rate of shunt insertion was observed in the youngest group (Group 1, 63.0%) when compared with older groups (Group 2, 46.4%; Group 3, 26.3%; Group 4, 38.6%; and Group 5, 30.8%; p = 0.03). Similarly, for patients who underwent ETV as their initial neuroendoscopic procedure or in combination with additional surgical interventions (n = 171), a significantly higher rate of shunt insertion was also observed within young infants (Group 1, 67.9%; Group 2, 47.6%; Group 3, 19.6%; Group 4, 27.3%; and Group 5, 23.3%; p = 0.003). CONCLUSIONS Intraventricular endoscopy is a safe neurosurgical intervention in pediatric patients of all ages, although it might be associated with increased shunt rates after endoscopic surgery, specifically ETV, in younger infants.
I ntraventrIcular endoscopy is a firmly established neurosurgical approach in children. Several techniques are used routinely across a wide spectrum of pathologies, including obstructive hydrocephalus, 2, 3, 8, 12 intracranial cysts, 5, 9, 11, 14, 19, 23 and intra-as well as paraventricular tumors. 1, 17, 18 However, the rates of success and complications after intraventricular endoscopic surgery are highly variable, which may reflect different prognoses between patients of different ages. 7, 10, 16, 20 While numerous studies have successfully reported on the safety of neuroendoscopic techniques in the pediatric population, 4, 15 neuroendoscopic surgery in infants younger than 1 year poses a particular clinical research challenge. 6, 16 Inconsistencies commonly arise between studies, particularly when defining success rates, selection criteria, or events leading to surgical failure in young infants. 6 Despite previous overwhelming support for the use of intraventricular endoscopy in young children, the International Infant Hydrocephalus Study has recently concluded that a ventriculoperitoneal shunt may be superior to endoscopic third ventriculostomy (ETV) for hydrocephalus in infants. 16 That study was the first prospective, multicenter study of its kind, strongly suggesting that the role of the child's age in the efficacy of neuroendoscopic procedures is not completely understood.
The principal aim of this study was to review the safety of intraventricular endoscopy across pediatric age groups and to determine whether it is associated with an increased risk of complications or reduced efficacy in infants younger than 1 year.
Methods
In this retrospective cohort study, paper/electronic clinical records and images obtained in 286 pediatric patients younger than 17 years who had undergone intraventricular endoscopy at Great Ormond Street Hospital (GOSH) between December 2005 and December 2014 were reviewed. The study was registered as a clinical audit and service evaluation at GOSH; at our institution, ethics board review is not required for anonymized retrospective audits of this kind. The primary neurosurgical diagnosis, procedure type, and complications were recorded for each patient. CSF infection was defined as a positive finding on CSF culture. The need for further definitive CSF diversion was defined as the development of clinically significant hydrocephalus. Seven neuroendoscopic procedures were performed in children younger than 1 month; their age was not corrected for gestational age.
All statistical analyses were performed using SigmaPlot software (version 12.0, Systat Software, Inc.). Chi-square analysis was used to compare overall complication rates, CSF infection rates, CSF diversion surgery, and ETV success rates across different age groups (0-6 months [ 
Results
A total of 286 consecutive pediatric patients, age up to 17 years, underwent intraventricular endoscopy for a number of neurosurgical indications. There were 51 neonates in Group 1, 37 Table 1 ). The majority of primary neuroendoscopic procedures performed in patients 0-12 months old was for the treatment of CSF-related disorders (i.e., hydrocephalus and arachnoid/porencephalic cysts) (Group 1, 72.5%; Group 2, 73.0%; Group 3, 66.7%; Group 4, 37.0%; and Group 5, 42.0%), whereas a higher proportion of neuroendoscopic procedures was performed for the management of intracranial tumors in patients aged 1 year and older (Table 2 ) (Group 1, 11.8%; Group 2, 5.4%; Group 3, 32.0%; Group 4, 57.4%; and Group 5, 56.5%).
Nine different complications attributable to intraventricular endoscopy were identified ( Table 3 ). The 4 most common complications included CSF leakage (3.1%), CSF infection (2.4%), postoperative seizures (1.7%), and intra- cranial hemorrhage (1.7%). The overall complication rate for all patients was 11.9% (Table 3 ) (Group 1, 9.8%; Group 2, 24.3%; Group 3, 4.0%; Group 4, 16.7%; and Group 5, 11.6%). There was no significant difference in complication rates between age groups (p = 0.401; Fig. 1A ). In the current study, the overall infection rate was 2.4% with no CSF infections being reported within the 0-to 6-month cohort (Group 1, 0%; Group 2, 5.4%; Group 3, 2.7%; Group 4, 3.7%; and Group 5, 1.4%). Similarly, there was no significant difference in infection rates between age groups (p = 0.912; Fig. 1B ).
Of 171 patients who underwent ETV as their initial neuroendoscopic procedure or in combination with additional surgical interventions, there was a significantly higher rate of subsequent shunt insertions in young infants than in older pediatric patients (Group 1, 67.9%; Group 2, 47.6%; Group 3, 19.6%; Group 4, 27.3%; and Group 5, 23.3%; p = 0.003) (Fig. 1C) . Similarly, after neuroendoscopic surgery for CSF diversion, including ETV and endoscopic septum pellucidotomy (n = 227), a significantly higher rate of shunt insertion was observed in patients in Group 1 (63.0%) compared with older age groups (Group 2, 46.4%; Group 3, 26.3%; Group 4, 38.6%; and Group 5, 30.8%; p = 0.030) (Fig. 1D) . 
Discussion
The primary objective of our study was to evaluate the safety of intraventricular endoscopy in pediatric patients, with a specific aim to determine whether age at intervention influences the efficacy of such procedures and the need for definitive CSF diversion surgery. The ages of our 286 pediatric patients ranged from 7 days to 17 years and the cases included a wide variety of neurosurgical pathologies from obstructive hydrocephalus and intracranial cysts to intracranial tumors and intracranial infections, making this one of the largest reported case series (Table 1) . Seven neuroendoscopic procedures were performed in infants younger than 1 month. As hydrocephalus is probably the most common pathology requiring neurosurgical intervention in pediatric patients, 6 ,10 it is not surprising that the majority of patients within the current study underwent ETV (n = 159) for the management of CSF-related disorders (defined at GOSH as hydrocephalus or nontumor cysts, e.g., arachnoid or porencephalic), closely followed by the biopsy and/or resection of intracranial tumors (n = 102) ( Table 2 ). As expected, primary diagnosis varied according to age, with younger infants more likely to require intraventricular surgery for the management of CSFrelated disorders, whereas for older pediatric patients, the indication for neuroendoscopy was more commonly tumor related (Table 2) .
In this present study, the overall complication rate was 11.9%. The most common complications included postoperative seizures (1.7%), CSF leak (3.1%), CSF infection (2.4%), and intracranial hemorrhage (1.7%) ( Table 3) . Interestingly, there was no significant difference in the rate of complications between age groups (p = 0.401; Fig. 1A ), suggesting that intraventricular endoscopy is equally safe in young infants and older children. Although there are several large series documenting the complication rates of ETV, 3, 4, 7, 8, 21 few publications have reviewed pediatric endoscopic procedures as a whole. 10 Despite this, our complication rates are comparable to those in previously published studies. 7, 10 In agreement with our study, a detailed consecutive analysis of 200 neuroendoscopic procedures performed in 177 pediatric patients reported an overall complication rate of 11% with no difference in complication rates between separate age groups (0-6 months, 6-12 months, and ≥ 1 year). 10 Hence, we conclude that intraventricular surgery is safe among the youngest age groups, including those younger than 1 year of age.
In our cohort, the overall CSF infection rate was 2.4%. Specifically, no CSF infections were reported within the 0-to 6-month age group (Group 1), with a similar rate of CSF infections recorded across all other age groups (0% in Group 1, 5.4% in Group 2, 2.7% in Group 3, 3.7% in Group 4, and 1.4% in Group 5). Our results are comparable to those in the published literature, with Elgamal et al. and Furlanetti et al. reporting overall CSF infection rates of 2.0% and 4.0%, respectively. 7,10 Importantly, there was no significant difference in CSF infection rates between age groups (p = 0.912) (Fig. 1B) .
Of 171 pediatric patients who underwent ETV as their initial neuroendoscopic procedure or in combination with other neurosurgical procedures, there was a significantly higher rate of subsequent shunt insertion within younger age groups than for older pediatric patients (p = 0.003) (Fig. 1C) . In particular, 67.9% of young infants (Group 1) went on to undergo further CSF shunting procedures compared with only 23.3% in children ≥ 10 years. The overall shunt rate post-ETV was 33%. In agreement with our study, Oertel et al. reported a 26% overall shunt rate post-ETV in pediatric patients younger than 18 years. 20 Once again, infants within their first 6 months of life more frequently required shunts; however, there was no significant difference between separate age groups (children < 14 years and < 2 years). 20 Similarly, in a recent study by Jernigan et al., it was concluded that a higher failure rate might occur after ETV than after shunt placement in infants younger than 1 year with hydrocephalus. 13 We conclude that ETV failure and the need for further CSF shunting is more likely in young infants. Although the mechanisms behind ETV failure in young infants remain unclear, a likely cause is CSF pathway closure via the formation of new arachnoid membranes or the development of scar tissue.
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Of interest, disappointing success rates and the need for definitive shunting in young infants are not solely limited to ETV alone. In our study, neuroendoscopic surgery for CSF diversion including ETV and endoscopic septostomy (n = 227) was also more likely to be unsuccessful in younger age groups (p = 0.030) (Fig. 1D) . More specifically, 63.0% of patients in the 0-to 6-month cohort who underwent any CSF-diverting procedure eventually required further shunt insertion surgery compared with only 30.8% within the cohort aged 10 years and older. Therefore, we conclude that patient age plays a vital role in the efficacy of neuroendoscopic surgery for CSF diversion. Despite lower success rates in young infants compared with older children, neuroendoscopy remains a safe and useful option in this group.
As our study aims to compare the complications associated with neuroendoscopic surgery from a relatively small population of patients, we should be cautious in the interpretation of our results. In addition, this is not a randomized study comparing neuroendoscopy to other CSF diversion procedures. In the context of clinical equipoise between ETV and shunting during the study period, our institution favored endoscopic CSF diversion as the firstline procedure in infants with obstructive hydrocephalus; however, the risks and benefits of shunts and ETV were always discussed with parents, and their wishes were always taken into account. Infants who underwent primary shunting were excluded from this study. We are aware that, despite a 9-year study period and a consistent approach, a degree of selection bias may still have been introduced. Further studies should aim to elucidate prognostic factors to adequately guide neurosurgical case selection, as well as combining sample populations from several different neurosurgical centers.
Conclusions
In our cohort of 286 pediatric patients, we report a similar rate of complications, including CSF infections, across separate age groups. We conclude that intraventricular endoscopy is a safe neurosurgical intervention in pediatric patients of all ages. However, the risk of ETV failure and subsequent shunt insertion post-ETV is higher in infants, specifically those younger than 1 year. In addition, young infants who undergo any CSF-diverting neuroendoscopic surgery may also be prone to experiencing higher failure rates. It is likely that careful case selection and surgical planning is crucial in young infants requiring neuroendoscopy.
